Enliven Therapeutics Stock Number Of Employees
| ELVN Stock | 23.94 0.96 4.18% |
Enliven Therapeutics fundamentals help investors to digest information that contributes to Enliven Therapeutics' financial success or failures. It also enables traders to predict the movement of Enliven Stock. The fundamental analysis module provides a way to measure Enliven Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Enliven Therapeutics stock.
Enliven | Number Of Employees |
Enliven Therapeutics Company Number Of Employees Analysis
Enliven Therapeutics' Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Current Enliven Therapeutics Number Of Employees | 50 |
Most of Enliven Therapeutics' fundamental indicators, such as Number Of Employees, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Enliven Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enliven Number Of Employees Driver Correlations
Understanding the fundamental principles of building solid financial models for Enliven Therapeutics is extremely important. It helps to project a fair market value of Enliven Stock properly, considering its historical fundamentals such as Number Of Employees. Since Enliven Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Enliven Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Enliven Therapeutics' interrelated accounts and indicators.
Click cells to compare fundamentals
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
| Competition |
Based on the recorded statements, Enliven Therapeutics is currently employing 50.0 people. This is 99.55% lower than that of the Pharmaceuticals sector and 90.66% lower than that of the Health Care industry. The number of employees for all United States stocks is 99.73% higher than that of the company.
Enliven Number Of Employees Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Enliven Therapeutics' direct or indirect competition against its Number Of Employees to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Enliven Therapeutics could also be used in its relative valuation, which is a method of valuing Enliven Therapeutics by comparing valuation metrics of similar companies.Enliven Therapeutics is currently under evaluation in number of employees category among related companies.
Enliven Therapeutics ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Enliven Therapeutics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Enliven Therapeutics' managers, analysts, and investors.Environmental | Governance | Social |
Enliven Fundamentals
| Return On Equity | -0.26 | ||||
| Return On Asset | -0.18 | ||||
| Current Valuation | 805.81 M | ||||
| Shares Outstanding | 47.04 M | ||||
| Shares Owned By Insiders | 6.77 % | ||||
| Shares Owned By Institutions | 90.53 % | ||||
| Number Of Shares Shorted | 5.3 M | ||||
| Price To Book | 4.00 X | ||||
| EBITDA | (83.23 M) | ||||
| Net Income | (71.58 M) | ||||
| Total Debt | 335 K | ||||
| Book Value Per Share | 6.79 X | ||||
| Cash Flow From Operations | (61.27 M) | ||||
| Short Ratio | 9.27 X | ||||
| Earnings Per Share | (1.75) X | ||||
| Target Price | 34.67 | ||||
| Number Of Employees | 50 | ||||
| Market Capitalization | 1.13 B | ||||
| Total Asset | 271.87 M | ||||
| Retained Earnings | (154.45 M) | ||||
| Working Capital | 240.26 M | ||||
| Net Asset | 271.87 M |
About Enliven Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Enliven Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Enliven Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Enliven Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Enliven Therapeutics Piotroski F Score and Enliven Therapeutics Altman Z Score analysis. To learn how to invest in Enliven Stock, please use our How to Invest in Enliven Therapeutics guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Complementary Tools for Enliven Stock analysis
When running Enliven Therapeutics' price analysis, check to measure Enliven Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enliven Therapeutics is operating at the current time. Most of Enliven Therapeutics' value examination focuses on studying past and present price action to predict the probability of Enliven Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enliven Therapeutics' price. Additionally, you may evaluate how the addition of Enliven Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |
Is Enliven Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enliven Therapeutics. If investors know Enliven will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enliven Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.75) | Return On Assets (0.18) | Return On Equity (0.26) |
The market value of Enliven Therapeutics is measured differently than its book value, which is the value of Enliven that is recorded on the company's balance sheet. Investors also form their own opinion of Enliven Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Enliven Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enliven Therapeutics' market value can be influenced by many factors that don't directly affect Enliven Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enliven Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Enliven Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enliven Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.